A trial looking at V940 and pembrolizumab for urothelial (urinary tract) cancer after surgery

This trial is looking at the combination of a treatment called V940 and pembrolizumab for urothelial cancer. It is comparing this to having pembrolizumab on its own. It is for people whose cancer:

• had grown into the muscle layer of the bladder or upper urinary tract and they have had surgery with the aim to cure

• has a higher chance of coming back